Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).

See also
Status	Clinical Trial	Phase
Completed	`NCT04467697` - Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men	Phase 3
Completed	`NCT04326673` - Salivary Testosterone in Men: Diurnal Variation and Post-Prandial Responses
Completed	`NCT03203681` - Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters	Phase 4
Completed	`NCT01904734` - Clomid in Men With Low Testosterone With and Without Prior Treatment	Phase 2
Completed	`NCT00398580` - 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men	Phase 2
Completed	`NCT00400335` - Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride	Phase 1
Recruiting	`NCT05611307` - Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Completed	`NCT03282682` - Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male	N/A
Terminated	`NCT03335254` - A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males	Phase 1/Phase 2
Terminated	`NCT05205837` - A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial	Phase 4
Completed	`NCT03747003` - Gonadal Function in Young to Middle Aged HIV-infected Men
Withdrawn	`NCT03176537` - Periodontal Profile of Hypogonadic Men	Phase 4
Recruiting	`NCT04049331` - Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone	Phase 2
Completed	`NCT03541395` - Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males	N/A
Recruiting	`NCT05249634` - Testosterone Treatment in Men With Chronic Kidney Disease	Phase 2
Not yet recruiting	`NCT05773183` - Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
Withdrawn	`NCT04717362` - The Effects of Natesto For Treatment Of Hypogonadism	Early Phase 1
Completed	`NCT05806723` - Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men	Phase 4
Completed	`NCT04456296` - A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism	Phase 4
Not yet recruiting	`NCT06312761` - Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17	Phase 1/Phase 2

NCT number	NCT03242590
Study type	Interventional
Source	Lipocine Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	December 2016
Completion date	July 2017

Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). — DV

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms